Comerica Bank
SMMT icon

Comerica Bank’s Summit Therapeutics SMMT Stock Holding History

Comerica Bank’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$560 Sell
32
-732
-96% -$13.8K ﹤0.01% 3628
2025
Q3 		$15.8K Sell
764
-119
-13% -$2.89K ﹤0.01% 3150
2025
Q2 		$18.8K Buy
883
+861
+3,914% +$19.6K ﹤0.01% 3066
2025
Q1 		$424 Hold
22
– – ﹤0.01% 3612
2024
Q4 		$393 Buy
+22
New +$426 ﹤0.01% 3618

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCMH
Polymer Capital Management (HK) Hong Kong $1.16B AUM 135.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Comerica Bank's SMMT Position: Q4 2025 in Review

Comerica Bank reduced its Summit Therapeutics (SMMT) stake by 96% in Q4 2025, selling an estimated $13.8K and leaving 32 shares worth $560. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

Comerica Bank first reported a position in SMMT in Q4 2024 and has held it in 5 quarters since. The position peaked at $18.8K in Q2 2025. 206 funds tracked by Wall St. Rank hold SMMT as of Q4 2025.

  • Comerica Bank held 32 shares of Summit Therapeutics worth $560 as of Q4 2025.
  • Comerica Bank sold 732 Summit Therapeutics shares in Q4 2025, an estimated $13.8K.
  • Summit Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3628 holding.
  • Comerica Bank first reported a position in Summit Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Comerica Bank's Summit Therapeutics position peaked at $18.8K in Q2 2025.
  • 206 funds tracked by Wall St. Rank held Summit Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.